Key facts
- This page summarizes William Strohl's Form 4 filing for IGM Biosciences, Inc. (IGMS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Aug 2024, 20:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-eighth of the RSUs shall vest on each of August 15, 2024, October 31, 2024, January 31, 2025, April 30, 2025, July 31, 2025, October 31, 2025, January 31, 2026 and April 30, 2026, subject to the Reporting Person continuing to provide consulting services to the Issuer through each such date. Vested RSUs will be delivered to the Reporting Person on the earlier of (i) the first quarterly release date (March 12, June 12, September 12 or December 12) following the Reporting Person's separation from service with the Issuer or (ii) immediately prior to a change in control of the Issuer.